Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)
- Status
- COMPLETED
- Phase
- PHASE1
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE2
AB122 Platform Study
- Status
- RECRUITING
- Phase
- PHASE1
Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery
- Status
- TERMINATED
- Phase
- PHASE1
A Study of SEA-CD40 Given With Other Drugs in Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3